Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 6Myelodysplastic Syndromes 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Anemia, Refractory, with Excess of Blasts 2Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Hematologic Diseases 1Blast Crisis 1Anemia, Refractory 1

Interventions

Cyclophosphamide 37fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 29Methotrexate 27Busulfan 26Tacrolimus 24Cytarabine 21Antilymphocyte Serum 20Cyclosporine 19Mycophenolic Acid 18Whole-Body Irradiation 17Radiotherapy 15Methylprednisolone 15Filgrastim 13merphos 10Melphalan 10Cord Blood Stem Cell Transplantation 10Imatinib Mesylate 9Etoposide 9Granulocyte Colony-Stimulating Factor 7Thiotepa 6Rituximab 6sargramostim 5fludarabine 5Vincristine 5Sirolimus 5Prednisone 5Idarubicin 5Cladribine 5thymoglobulin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Blast Crisis × lintuzumab × Clear all
NCT00002800 2013-07-03

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡